未登录 CD8+Tcells in the tumor microenvironment modulate the response to endocrine therapy in breast cancer 肿瘤微环境中的CD8+T细胞调节乳腺癌对内分泌治疗的反应 Napolitano, Fabiana; Wang, Yunguan; Sudhan, Dhivya R.; Gonzalez-Ericsson, Paula I.; Formisano, Luigi; Unni, Nisha; Shakeel, Shahbano; Zhu, James Z.; Ahuja, Khushi; Guo, Lei; Chica-Parrado, Maria Rosario; Matsunaga, Yuki; Luna, Pamela; Lin, Chang-Ching A.; Uemoto, Yasuaki; Lee, Kyung-Min; Ma, Hongli; Evans, Nathaniel J.; Servetto, Alberto; Mendiratta, Saurabh; Barnes, Spencer D.; Bianco, Roberto; V. Fang, Yisheng; Xu, Lin; Lee, Jeon; Wang, Tao; Balko, Justin M.; Mills, Gordon B.; Labrie, Marilyne; Hanker, Ariella B.; Arteaga, Carlos L. 分享 收藏
Performance of Control Arms in Trials Leading to FDA Cancer Approvals FDA癌症审批试验中控制臂的性能 Viggiano, Angela; Salomone, Fabio; Napolitano, Fabiana; Liguori, Luigi; Avanzo, Annarita; D'ambrosio, Simeone; Vitale, Filippo; Isernia, Maria Carmela; Russo, Anna; Longo, Lucia; Pepe, Felice; Santaniello, Antonio; Viscardi, Giuseppe; Vitiello, Fabiana; Gilli, Marina; Formisano, Luigi; Bianco, Roberto; Servetto, Alberto 分享 收藏
分享 收藏
分享 收藏
Censoring in trials testing immunotherapy in advanced cancers: a systematic review and a meta-research study Vitale, Filippo; Salomone, Fabio; Di Maio, Massimo; D'Ambrosio, Simeone; Avanzo, Annarita; Napolitano, Fabiana; Viggiano, Angela; Liguori, Luigi; Russo, Anna; Isernia, Maria Carmela; Longo, Lucia; Santaniello, Antonio; Formisano, Luigi; Bianco, Roberto; Servetto, Alberto 分享 收藏
Corrigendum to “Combined inhibition of CDK4/6 and AKT is highly effective against the luminal androgen receptor (LAR) subtype of triple negative breast cancer” [604 (2024) 217219 1–12] 勘误:“联合抑制CDK4/6和AKT对三阴性乳腺癌的腔内雄激素受体(LAR)亚型具有高度有效性” [604 (2024) 217219 1–12] Chica-Parrado, Maria Rosario; Kim, Gun Min; Uemoto, Yasuaki; Napolitano, Fabiana; Lin, Chang-Ching; Ye, Dan; Bikorimana, Emmanuel; Fang, Yisheng; Lee, Kyung-min; Mendiratta, Saurabh; Hanker, Ariella B.; Arteaga, Carlos L. 分享 收藏
分享 收藏
分享 收藏
Selective degradation of FGFR1/2 overcomes antiestrogen resistance in ER+ breast cancer with FGFR1/2 alterations (vol 619, 217668, 2025) FGFR1/2的选择性降解克服了具有FGFR1/2改变的ER+乳腺癌的抗雌激素耐药性(卷619,217668,2025) Uemoto, Yasuaki; Lin, Chang-Ching A.; Wang, Bingnan; Ye, Dan; Fang, Yisheng, V; Bikorimana, Emmanuel; Napolitano, Fabiana; Chica-Parrado, Maria Rosario; Li, Cheung; Mendiratta, Saurabh; Chen, Chuo; Hanker, Ariella B.; Arteaga, Carlos L. 分享 收藏
Blinded independent central review versus local investigator assessment of PFS in RCTs of immunotherapy in advanced cancers: A systematic review and meta-analysis D'Ambrosio, Simeone; Salomone, Fabio; Vitale, Filippo; Avanzo, Annarita; Viggiano, Angela; Liguori, Luigi; Ferrara, Roberto; Nuccio, Antonio; Viscardi, Giuseppe; Napolitano, Fabiana; Santaniello, Antonio; Formisano, Luigi; Bianco, Roberto; Servetto, Alberto 分享 收藏
Combined inhibition of CDK4/6 and AKT is highly effective against the luminal androgen receptor (LAR) subtype of triple negative breast cancer Chica-Parrado, Maria Rosario; Kim, Gun Min; Uemoto, Yasuaki; Napolitano, Fabiana; Lin, Chang-Ching; Ye, Dan; Bikorimana, Emmanuel; Fang, Yisheng; Lee, Kyung-min; Mendiratta, Saurabh; Hanker, Ariella B.; Arteaga, Carlos L. 分享 收藏
Mapping cellular interactions from spatially resolved transcriptomics data Zhu, James; Wang, Yunguan; Chang, Woo Yong; Malewska, Alicia; Napolitano, Fabiana; Gahan, Jeffrey C.; Unni, Nisha; Zhao, Min; Yuan, Rongqing; Wu, Fangjiang; Yue, Lauren; Guo, Lei; Zhao, Zhuo; Chen, Danny Z.; Hannan, Raquibul; Zhang, Siyuan; Xiao, Guanghua; Mu, Ping; Hanker, Ariella B.; Strand, Douglas; Arteaga, Carlos L.; Desai, Neil; Wang, Xinlei; Xie, Yang; Wang, Tao 分享 收藏
Assessing differential informative censoring in control and experimental arm in trials testing immunotherapy in metastatic cancers: A systematic review 评估免疫疗法在转移性癌症临床试验中对照组和实验组差异信息性删失的系统性综述 Vitale, F.; Salomone, F.; D'Ambrosio, S.; Avanzo, A.; Viggiano, A.; Liguori, L.; Napolitano, F.; Santaniello, A.; Formisano, L.; Bianco, R.; Servetto, A. 分享 收藏
Analysis of correlation between quality of life (QoL) results and survival outcomes in phase III clinical trials testing immunotherapy in metastatic cancers 生活质量(QoL)结果与生存结局之间的相关性分析:基于评估免疫疗法在转移性癌症中应用的III期临床试验 Avanzo, A.; Salomone, F.; D'Ambrosio, S.; Vitale, F.; Viggiano, A.; Liguori, L.; Napolitano, F.; Santaniello, A.; Formisano, L.; Bianco, R.; Servetto, A. 分享 收藏
Blinded independent central review versus local investigator assessment of progression-free survival in randomized controlled trials of immunotherapy in advanced cancers: A systematic review and meta-analysis 盲法独立中心评估与局部研究者评估在晚期癌症免疫疗法随机对照试验中无进展生存期的比较:一项系统评价和Meta分析 D'Ambrosio, S.; Salomone, F.; Vitale, F.; Avanzo, A.; Viggiano, A.; Liguori, L.; Napolitano, F.; Santaniello, A.; Formisano, L.; Bianco, R.; Servetto, A. 分享 收藏
分享 收藏
A bedside-to-bench translational analysis demonstrates that NF1 alterations promote CDK4/6 inhibitor (CDK4/6i) resistance in hormone receptor-positive (HR plus ) metastatic breast cancer (MBC) Lloyd, Maxwell; Chica-Parrado, M. Rosario; Knepper, Todd; Lin, Chang-Ching; Podany, Emily; Walko, Christine; Napolitano, Fabiana; Weipert, Caroline; Liao, Jiemin; Medford, Arielle; Ryan, Lianne; Keenan, Jennifer; Zhang, Nicole; Liu, Shiyuan; Wulf, Gerburg; Clifton, Katherine; Ma, Cynthia; Han, Hyo; Ellisen, Leif; Bardia, Aditya; Arteaga, Carlos; Hanker, Ariella; Wander, Seth 分享 收藏
Tumor immune microenvironment modulates resistance to estrogen suppression in ER plus breast cancer Napolitano, Fabiana; Wang, Yunguan; Sudhan, Dhivya; Gonzalez-Ericsson, Paula; Formisano, Luigi; Guo, Lei; Chica-Parrado, M. Rosario; Lin, Chang-Ching; Lee, Kyung-Min; Ma, Hongli; Evans, Nathaniel; Servetto, Alberto; Mendiratta, Saurabh; Barnes, Spencer; Fang, Yisheng; Xu, Lin; Balko, Justin; Mills, Gordon; Labrie, Marilyne; Hanker, Ariella; Arteaga, Carlos 分享 收藏
ESR1 mutations drive resistance to CDK4/6 inhibitors in ER plus Breast Cancer Chica-Parrado, M. Rosario; Lin, Chang-Ching; Jaeger, Ellen; Harris, Michelle; Guo, Lei; Bikorimana, Emmanuel; Napolitano, Fabiana; Chao, Calvin; Hanker, Ariella; Arteaga, Carlos 分享 收藏
Combined inhibition of CDK4/6 and AKT is highly active against the luminal androgen receptor (LAR) subtype of triple negative breast cancer (TNBC) Chica-Parrado, Rosario; Kim, Gun Min; Uemoto, Yasuaki; Ye, Dan; Napolitano, Fabiana; Lin, Chang-Ching; Bikorimana, Emmanuel; Lee, Kyung-Min; Mendiratta, Saurabh; Hanker, Ariella B.; Arteaga, Carlos L. 分享 收藏